The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
We take a proactive approach in monitoring the potential impacts of all types of breast implants including the newer models. We aim to minimise implant related hazards, detect any adverse effects early, and take regulatory action quickly if needed.
This framework outlines our processes to identify and manage risk. It contains useful information on what consumers and health care professionals can do to be vigilant. It describes the cooperative efforts that could be used by health care professionals, experts in the field, international regulators and consumer advocates in the on-going monitoring and gathering of real-world evidence.